Clinical Trials Browser

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT03490032 2020-11-17

PROfind

Phase 1/2 Completed

30 enrolled 30 charts

Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT02606123 2018-03-01

Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Terminated

28 enrolled

Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms

NCT02049190 2015-06-24

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Phase 1/2 Unknown

75 enrolled

Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT00895466 2009-05-08

Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients

Phase 1/2 Unknown

12 enrolled

Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms

Clinical Trials

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

P300

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

PROfind

Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients